Schizophrenia: open trials in Italy

12 open trials have a site in Italy. Registry data; only the trial team decides who can take part.

NCT06540833
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Trial Treatment · Phase 2 · Intra-Cellular Therapies, Inc.
Ospedale di Arzignano, Arzignano · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Presidio Spedali Civili, Brescia · Fondazione Istituto G. Giglio, Cefalù · Ospedale Cardinale G. Panico, Tricase
Registry updated 2026-11-03
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Provincia Lombardo Veneta Dell’Ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli, Brescia · Istituto Auxologico Italiano, Milan · Azienda Ospedaliero-Universitaria Sant Andre, Rome · Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome
Registry updated 2026-10-27
NCT06778564
Stratification and Treatment in Early Psychosis Study - ENHANCE
Trial Treatment · Phase 3 · University of Oxford
University of Campania "Luigi Vanvitelli", Naples
Registry updated 2026-10-08
NCT07326124
Stratification and Treatment in Early Psychosis Study -ASSIST
Trial Treatment · Phase 3 · University of Oxford
University of Campania "Luigi Vanvitelli", Naples
Registry updated 2026-10-08
NCT07434973
Stratification and Treatment in Early Psychosis Study - PROMOTE
Trial Treatment · Phase 3 · University of Oxford
University Of Bari Aldo Moro, Bari · University of Campania L. Vanvitelli, Naples · University of Pavia, Pavia · IRCCS Santa Lucia Foundation, Roma
Registry updated 2026-10-08
NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon, Rome · Pia Fondazione Di Culto E Religione Card G Panico, Tricase
Registry updated 2026-09-30
2024-519836-18-00
Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
Trial Treatment · Phase 3 · Newron Pharmaceuticals S.p.A.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Azienda Socio Sanitaria Territoriale Santi Paolo E Carlo, Milan · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples · Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Naples · Azienda Ospedaliero-Universitaria Sant Andre, Rome
Registry updated 2026-08-21
NCT07459660
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon, Rome · Pia Fondazione Di Culto E Religione Card G Panico, Tricase
Registry updated 2026-08-07
NCT07649993
Non-Coding RNAs Gene Expression in Psychiatric Disorders
Research · Carmen Concerto
Psychiatry Unit, Via Santa Sofia 78, Catania · Psychiatry Unit, Contrada Ferrante SNC, Enna · Cellular and Molecular Biology Laboratory, Tower of Biological Laboratories, 5th Floor Via Consolare Valeria 1, Messina · Psychiatry Unit, Via Consolare Valeria 1, Messina · Psychiatry Unit, Via del Vespro 129, Palermo
Registry updated 2026-06-23
NCT05958875
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Trial Treatment · Phase 4 · Dr. Inge Winter
University of Brescia, Brescia · Clinica Psichiatrica, 1st floor, Cagliari · Universita degli Studi della Campania Luigi Vanvitelli, Naples · Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino, Turin
Registry updated 2025-09-26
NCT06886945
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
Research · IRCCS Centro San Giovanni di Dio Fatebenefratelli
IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia
Registry updated 2025-03-20
2023-508981-13-00
A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavailability at Steady-State of LY03010 versus XEPLION® in Patients with Schizophrenia
Trial Treatment · Phase 1 · Geneora Pharma (Shijiazhuang) Co. Ltd.
MENTAL HEALTH CENTER PROF. DR. IVAN TEMKOV, Bourgas
Registry updated 2024-08-27

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error